On 10/1, the Lobular Breast Cancer Awareness tour bus visited Nebraska Hematology-Oncology and Wellity, bringing conversations about ILC into cancer care and the local community. Thank you to everyone who welcomed us and helped raise awareness! Follow along: lobularbreastcancer.org/awareness-day/
October 2, 2026 at 5:05 PM
On 10/1, the Lobular Breast Cancer Awareness tour bus visited Nebraska Hematology-Oncology and Wellity, bringing conversations about ILC into cancer care and the local community. Thank you to everyone who welcomed us and helped raise awareness! Follow along: lobularbreastcancer.org/awareness-day/
Mari Salinas, Phlebotomist 2 at U of VT Medical Center, represents in Support Staff union:
Lab Outreach, Pathology/Lab, Lab Customer Support, Lab General Support, Anatomic Pathology, Histology, Cytology,
Phlebotomy, Microbiology, Chemistry, & Hematology. 🇺🇸💪❤️‼️
supportstaffunited.org?page_id=1920
Lab Outreach, Pathology/Lab, Lab Customer Support, Lab General Support, Anatomic Pathology, Histology, Cytology,
Phlebotomy, Microbiology, Chemistry, & Hematology. 🇺🇸💪❤️‼️
supportstaffunited.org?page_id=1920
Our Executive Board – UVMMC Support Staff United
supportstaffunited.org
October 2, 2026 at 3:56 PM
Mari Salinas, Phlebotomist 2 at U of VT Medical Center, represents in Support Staff union:
Lab Outreach, Pathology/Lab, Lab Customer Support, Lab General Support, Anatomic Pathology, Histology, Cytology,
Phlebotomy, Microbiology, Chemistry, & Hematology. 🇺🇸💪❤️‼️
supportstaffunited.org?page_id=1920
Lab Outreach, Pathology/Lab, Lab Customer Support, Lab General Support, Anatomic Pathology, Histology, Cytology,
Phlebotomy, Microbiology, Chemistry, & Hematology. 🇺🇸💪❤️‼️
supportstaffunited.org?page_id=1920
Advancing #hematology takes collaboration. Through the ASH Corporate Friends program, participating companies help support transformative research, innovative education, and high-quality, equitable care.
Learn more: https://ow.ly/VV6L50ZTVZk
Thank you to all participating companies!
Learn more: https://ow.ly/VV6L50ZTVZk
Thank you to all participating companies!
October 2, 2026 at 3:05 PM
Advancing #hematology takes collaboration. Through the ASH Corporate Friends program, participating companies help support transformative research, innovative education, and high-quality, equitable care.
Learn more: https://ow.ly/VV6L50ZTVZk
Thank you to all participating companies!
Learn more: https://ow.ly/VV6L50ZTVZk
Thank you to all participating companies!
SAVE THIS LINK ashpublications.org/bloodadvance...
American Society of Hematology 2026 guidelines for diagnosis of iron deficiency
Background: Iron deficiency is the most common micronutrient deficiency, and when untreated progresses to anemia. Existing guidance on the diagnostic crite
ashpublications.org
October 2, 2026 at 2:12 PM
SAVE THIS LINK ashpublications.org/bloodadvance...
Area Business Manager, Hematology/Oncology - Rockford, Illinois - Remote, US Job educativ.net/jobs/job/66258...
October 2, 2026 at 10:03 AM
Area Business Manager, Hematology/Oncology - Rockford, Illinois - Remote, US Job educativ.net/jobs/job/66258...
Area Business Manager, Hematology/Oncology - Rockford, Illinois - Remote, US Job educativ.net/jobs/job/66258...
October 2, 2026 at 9:11 AM
Area Business Manager, Hematology/Oncology - Rockford, Illinois - Remote, US Job educativ.net/jobs/job/66258...
🎗️🧒 Do psychosocial interventions improve outcomes for children undergoing cancer treatment?
This systematic review & three-level meta-analysis found a moderate overall benefit across health outcomes, supporting the value of psychosocial care into pediatric oncology.
🔎 doi.org/10.1080/1743...
This systematic review & three-level meta-analysis found a moderate overall benefit across health outcomes, supporting the value of psychosocial care into pediatric oncology.
🔎 doi.org/10.1080/1743...
![Screenshot of the first page of a scientific journal article titled “Effectiveness of psychosocial interventions in pediatric oncology and hematology: a systematic review and three-level meta-analysis.” Authors: Maximilian Hopfgartner, Liesa Weiler-Wichtl, Lisa Glinsky, Ulrich S. Tran, and Martin Voracek.
Abstract: Background: This preregistered systematic review and meta-analysis aimed to comprehensively assess the effectiveness of psychosocial interventions on health outcomes in pediatric patients undergoing treatment for cancer. Methods: A systematic literature search was conducted across multiple databases. The review included studies reporting samples with children and/or adolescents undergoing cancer treatment, focusing on randomised controlled trials of psychosocial interventions with a quantified health outcome. A three-level meta-analytic approach was utilised. Results: A total of 74 studies (total N = 4526), providing 204 effect sizes, was eligible. The summary effect estimate was of medium size and nominally significant (Hedges g = 0.46, 95% CI [0.33–0.59]). Subgroup analyses revealed significant differences for health outcome and publication year only. Physiological outcomes showed a smaller effect (g = 0.14, 95% CI [−0.16–0.43]), and more recent publications showed larger effect sizes. Discussion: This research synthesis provides evidence supporting the impact of psychosocial interventions on health outcomes in pediatric oncology and hematology patients. Despite variations in study quality and heterogeneity of the primary literature corpus, psychosocial care emerged as beneficial across a diverse range of contexts.](https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:i7pdi5hn5k7temothifcoegh/bafkreidimhms3aj3c2rlh3jjdzhebkwt3mil6e5qypwv4uratbgvprgxyi)
October 2, 2026 at 8:51 AM
🎗️🧒 Do psychosocial interventions improve outcomes for children undergoing cancer treatment?
This systematic review & three-level meta-analysis found a moderate overall benefit across health outcomes, supporting the value of psychosocial care into pediatric oncology.
🔎 doi.org/10.1080/1743...
This systematic review & three-level meta-analysis found a moderate overall benefit across health outcomes, supporting the value of psychosocial care into pediatric oncology.
🔎 doi.org/10.1080/1743...
Immune Hematology Manager Great Lakes - Remote, US Job educativ.net/jobs/job/66258...
October 2, 2026 at 8:09 AM
Immune Hematology Manager Great Lakes - Remote, US Job educativ.net/jobs/job/66258...
Area Business Manager, Hematology/Oncology - Rockford, Illinois - Remote, US Job educativ.net/jobs/job/66258...
October 2, 2026 at 7:10 AM
Area Business Manager, Hematology/Oncology - Rockford, Illinois - Remote, US Job educativ.net/jobs/job/66258...
Area Business Manager, Hematology/Oncology - Rockford, Illinois - Remote, US Job educativ.net/jobs/job/66258...
October 2, 2026 at 6:44 AM
Area Business Manager, Hematology/Oncology - Rockford, Illinois - Remote, US Job educativ.net/jobs/job/66258...
Area Business Manager, Hematology/Oncology - Rockford, Illinois - Remote, US Job educativ.net/jobs/job/66258...
October 2, 2026 at 5:53 AM
Area Business Manager, Hematology/Oncology - Rockford, Illinois - Remote, US Job educativ.net/jobs/job/66258...
Immune Hematology Manager Great Lakes - Remote, US Job educativ.net/jobs/job/66258...
October 2, 2026 at 5:15 AM
Immune Hematology Manager Great Lakes - Remote, US Job educativ.net/jobs/job/66258...
Immune Hematology Manager Great Lakes - Remote, US Job educativ.net/jobs/job/66258...
October 2, 2026 at 2:49 AM
Immune Hematology Manager Great Lakes - Remote, US Job educativ.net/jobs/job/66258...
Area Business Manager, Hematology/Oncology - Rockford, Illinois - Remote, US Job educativ.net/jobs/job/66258...
October 2, 2026 at 2:19 AM
Area Business Manager, Hematology/Oncology - Rockford, Illinois - Remote, US Job educativ.net/jobs/job/66258...
Good. Hematology was there first.
October 2, 2026 at 1:55 AM
Good. Hematology was there first.
Job ID: 50386
Extract: The University of Toronto seeks a Hematological Pathologist at the rank of Assistant, Associate, or Full Professor. The candidate should have expertise in Hematopathology and Laboratory Hematology, with responsibilities in clinical practice, teaching, and research.
Extract: The University of Toronto seeks a Hematological Pathologist at the rank of Assistant, Associate, or Full Professor. The candidate should have expertise in Hematopathology and Laboratory Hematology, with responsibilities in clinical practice, teaching, and research.
October 2, 2026 at 1:41 AM
Job ID: 50386
Extract: The University of Toronto seeks a Hematological Pathologist at the rank of Assistant, Associate, or Full Professor. The candidate should have expertise in Hematopathology and Laboratory Hematology, with responsibilities in clinical practice, teaching, and research.
Extract: The University of Toronto seeks a Hematological Pathologist at the rank of Assistant, Associate, or Full Professor. The candidate should have expertise in Hematopathology and Laboratory Hematology, with responsibilities in clinical practice, teaching, and research.
The Cedars-Sinai Cancer 15th Annual New Therapeutics in Hematology and Oncology: The Road to Personalized Medicine conference will be taking place this Fall! Join us on Oct 13 to Oct 14 at the Sofitel Los Angeles at Beverly Hills. Click for more information: cedars.cloud-cme.com/course/cours...
October 2, 2026 at 1:08 AM
The Cedars-Sinai Cancer 15th Annual New Therapeutics in Hematology and Oncology: The Road to Personalized Medicine conference will be taking place this Fall! Join us on Oct 13 to Oct 14 at the Sofitel Los Angeles at Beverly Hills. Click for more information: cedars.cloud-cme.com/course/cours...
🌟 We extend our gratitude to Alexion for joining us as a gold-level exhibitor, and to Incyte, Disc Medicine, and Recordati Rare Diseases for joining us as silver-level exhibitors at the October 3rd HemeHub Hematology Summit.
🌐 Explore more: hemehub.org/events/hemehub
#HemeHub #HemeOnc
🌐 Explore more: hemehub.org/events/hemehub
#HemeHub #HemeOnc
October 2, 2026 at 12:52 AM
🌟 We extend our gratitude to Alexion for joining us as a gold-level exhibitor, and to Incyte, Disc Medicine, and Recordati Rare Diseases for joining us as silver-level exhibitors at the October 3rd HemeHub Hematology Summit.
🌐 Explore more: hemehub.org/events/hemehub
#HemeHub #HemeOnc
🌐 Explore more: hemehub.org/events/hemehub
#HemeHub #HemeOnc
🩸The HemeHub Hematology Summit is just 2 days away!
Here’s a preview of the schedule, bringing together expert insights and panel discussions for a full day of learning!
Full program and event details: hemehub.org/events/hemeh...
#HemeHub #HemeOnc #Myelofibrosis #MultipleMyeloma #CLL #PNH #DLBCL
Here’s a preview of the schedule, bringing together expert insights and panel discussions for a full day of learning!
Full program and event details: hemehub.org/events/hemeh...
#HemeHub #HemeOnc #Myelofibrosis #MultipleMyeloma #CLL #PNH #DLBCL
October 2, 2026 at 12:47 AM
🩸The HemeHub Hematology Summit is just 2 days away!
Here’s a preview of the schedule, bringing together expert insights and panel discussions for a full day of learning!
Full program and event details: hemehub.org/events/hemeh...
#HemeHub #HemeOnc #Myelofibrosis #MultipleMyeloma #CLL #PNH #DLBCL
Here’s a preview of the schedule, bringing together expert insights and panel discussions for a full day of learning!
Full program and event details: hemehub.org/events/hemeh...
#HemeHub #HemeOnc #Myelofibrosis #MultipleMyeloma #CLL #PNH #DLBCL
🌟 We extend our gratitude to Johnson & Johnson and Sanofi for joining us as gold-level exhibitors, and to BeOne Medicines and Biogen for joining us as silver-level exhibitors at the October 3rd HemeHub Hematology Summit.
🌐 Explore more: hemehub.org/events/hemeh...
#HemeHub #HemeOnc
🌐 Explore more: hemehub.org/events/hemeh...
#HemeHub #HemeOnc
October 2, 2026 at 12:46 AM
🌟 We extend our gratitude to Johnson & Johnson and Sanofi for joining us as gold-level exhibitors, and to BeOne Medicines and Biogen for joining us as silver-level exhibitors at the October 3rd HemeHub Hematology Summit.
🌐 Explore more: hemehub.org/events/hemeh...
#HemeHub #HemeOnc
🌐 Explore more: hemehub.org/events/hemeh...
#HemeHub #HemeOnc
🩸Our case discussion on Smoldering Multiple Myeloma with Shaji Kumar, MD and Adeel Khan, MD is now available to watch on YouTube!
⮕ Watch the full session: youtu.be/vbFJmFe0vjE?...
#SmolderingMyeloma #MultipleMyeloma #Myeloma #Hematology #HemOnc #Oncology #MedicalEducation #MedEd #HemeHub
⮕ Watch the full session: youtu.be/vbFJmFe0vjE?...
#SmolderingMyeloma #MultipleMyeloma #Myeloma #Hematology #HemOnc #Oncology #MedicalEducation #MedEd #HemeHub
October 2, 2026 at 12:40 AM
🩸Our case discussion on Smoldering Multiple Myeloma with Shaji Kumar, MD and Adeel Khan, MD is now available to watch on YouTube!
⮕ Watch the full session: youtu.be/vbFJmFe0vjE?...
#SmolderingMyeloma #MultipleMyeloma #Myeloma #Hematology #HemOnc #Oncology #MedicalEducation #MedEd #HemeHub
⮕ Watch the full session: youtu.be/vbFJmFe0vjE?...
#SmolderingMyeloma #MultipleMyeloma #Myeloma #Hematology #HemOnc #Oncology #MedicalEducation #MedEd #HemeHub
Hematology told me to get vitamin D today.
I can’t even afford food.
I can’t even afford food.
October 2, 2026 at 12:07 AM
Hematology told me to get vitamin D today.
I can’t even afford food.
I can’t even afford food.
🎙️ In case you missed any, read a recap of the episodes of #OncliveOnAir that aired in September 2026. @lpetrillz.bsky.social @matthewkurianmd.bsky.social #oncology #hematology
Read the full recap ➡️: www.onclive.com/view/revisit...
Read the full recap ➡️: www.onclive.com/view/revisit...
Revisit Every OncLive On Air Episode From September 2026 | OncLive
In case you missed any, read a recap of the episodes of OncLive On Air that aired in September 2026.
www.onclive.com
October 1, 2026 at 9:37 PM
🎙️ In case you missed any, read a recap of the episodes of #OncliveOnAir that aired in September 2026. @lpetrillz.bsky.social @matthewkurianmd.bsky.social #oncology #hematology
Read the full recap ➡️: www.onclive.com/view/revisit...
Read the full recap ➡️: www.onclive.com/view/revisit...
The 2027 Highlights of ASH are coming to cities around the world!
Following #ASH26, leading experts will explore what the latest #ASH26 findings mean for clinical practice and patient care in your region.
Register today: https://ow.ly/5pms50ZTtI7
#HemeSky #Hematology #HemeOnc #OncySky
Following #ASH26, leading experts will explore what the latest #ASH26 findings mean for clinical practice and patient care in your region.
Register today: https://ow.ly/5pms50ZTtI7
#HemeSky #Hematology #HemeOnc #OncySky
October 1, 2026 at 6:00 PM
The 2027 Highlights of ASH are coming to cities around the world!
Following #ASH26, leading experts will explore what the latest #ASH26 findings mean for clinical practice and patient care in your region.
Register today: https://ow.ly/5pms50ZTtI7
#HemeSky #Hematology #HemeOnc #OncySky
Following #ASH26, leading experts will explore what the latest #ASH26 findings mean for clinical practice and patient care in your region.
Register today: https://ow.ly/5pms50ZTtI7
#HemeSky #Hematology #HemeOnc #OncySky
🎧 New Episode Alert! 🎧🎙️ Listen now to the new episode of HemeTalks: Conversations in Hematology Education on From Aplastic Anemia to PNH: The Patient Perspective! #HemeTalks #MedicalPodcast #Hematology
From Aplastic Anemia to PNH: The Patient Perspective
In this episode of HemeTalks, we are joined by Ms. Elise Burton, who...
share.transistor.fm
October 1, 2026 at 3:55 PM
🎧 New Episode Alert! 🎧🎙️ Listen now to the new episode of HemeTalks: Conversations in Hematology Education on From Aplastic Anemia to PNH: The Patient Perspective! #HemeTalks #MedicalPodcast #Hematology